floxuridine has been researched along with Bone Neoplasms in 38 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the combination treatment consisted of 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA) was investigated in 20 recurrent breast cancer patients." | 9.08 | [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]. ( Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T, 1995) |
| "Two cases of metastatic breast cancer are reported in which endocrine chemotherapy with Toremifene + 5'-DFUR proved markedly effective." | 7.70 | [Endocrine chemotherapy (high-dose toremifene + 5'-DFUR) found markedly effective for 2 cases of metastatic breast cancer]. ( Kuroda, T; Mizutani, H; Nakamura, Y; Tadaoka, N; Takahashi, N, 1999) |
| "Two cases of recurrent breast cancer are reported in which chemotherapy with mitoxantrone proved remarkably effective." | 7.70 | [Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer]. ( Katagata, N; Matsuoka, T; Nomizu, T; Takenoshita, S; Tsuchiya, A; Watanabe, F; Yabuta, T; Yamaki, Y, 2000) |
| "Although most patients with gestational trophoblastic neoplasia (GTN) are cured by conventional chemotherapy, some develop drug resistance or relapse." | 5.37 | Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia. ( Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y, 2011) |
| "Two patients were diagnosed as advanced breast cancer with multiple bone metastases." | 5.33 | [Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)]. ( Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H, 2005) |
| "The effect of the combination treatment consisted of 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA) was investigated in 20 recurrent breast cancer patients." | 5.08 | [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]. ( Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T, 1995) |
| "A 42-year-old woman with multiple organ metastases from breast cancer was successfully treated with 5'-deoxy-5-fluorouridine (5'-DFUR) and hormonal therapy (leuprorelin+tamoxifen)." | 3.73 | [A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy]. ( Fukami, Y; Hasegawa, H; Hiromatsu, T; Itazu, K; Kawai, K; Komatsu, S; Sakamoto, E; Tabata, T, 2005) |
| "Two cases of metastatic breast cancer are reported in which endocrine chemotherapy with Toremifene + 5'-DFUR proved markedly effective." | 3.70 | [Endocrine chemotherapy (high-dose toremifene + 5'-DFUR) found markedly effective for 2 cases of metastatic breast cancer]. ( Kuroda, T; Mizutani, H; Nakamura, Y; Tadaoka, N; Takahashi, N, 1999) |
| "Two cases of recurrent breast cancer are reported in which chemotherapy with mitoxantrone proved remarkably effective." | 3.70 | [Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer]. ( Katagata, N; Matsuoka, T; Nomizu, T; Takenoshita, S; Tsuchiya, A; Watanabe, F; Yabuta, T; Yamaki, Y, 2000) |
| "Growth inhibition assays indicated that the IC50 values for methotrexate (MTX) and 5-fluorodeoxyuridine (FdUrd) in HS-18, a liposarcoma cell line lacking retinoblastoma protein (pRB), and SaOS-2, an osteosarcoma cell line with a truncated and nonfunctional pRB, were 10- to 12-fold and 4- to 11-fold higher, respectively, than for the HT-1080 (fibrosarcoma) cell line, which has wild-type pRB." | 3.69 | Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. ( Almasan, A; Banerjee, D; Bertino, JR; Fan, J; Hochhauser, D; Kelly, R; Li, W; Wahl, GM; Yin, Y; Zielinski, Z, 1995) |
| " Therapeutic safety was evaluated by analyses of adverse events with the recommended dose." | 2.72 | [Evaluation of safety and efficacy for bi-weekly Docetaxel and 5'-DFUR combination therapy in patients with advanced or recurrent breast cancer--Phase I study]. ( Ikeda, M; Ishiguro, K; Kataoka, T; Komaki, K; Kurebayashi, J; Morimoto, T; Sonoo, H; Tanaka, K; Tangoku, A; Yoshizawa, K, 2006) |
| " The purpose of the present study was to examine the efficacy of long-term administration of 5'-DFUR/CPA for patients with recurrent breast cancer." | 2.71 | The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer. ( Aihara, N; Fukunaga, M; Iba, T; Kidokoro, A; Suda, M; Sugiyama, K, 2004) |
| "Although most patients with gestational trophoblastic neoplasia (GTN) are cured by conventional chemotherapy, some develop drug resistance or relapse." | 1.37 | Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia. ( Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y, 2011) |
| "Gemcitabine was rapidly eliminated from plasma even in patients with renal dysfunction." | 1.35 | Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer. ( Hirobe, M; Itoh, T; Kunishima, Y; Masumori, N; Takayanagi, A; Takeuchi, M; Tsukamoto, T, 2008) |
| "Two patients were diagnosed as advanced breast cancer with multiple bone metastases." | 1.33 | [Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)]. ( Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H, 2005) |
| " Two months later a side effect of MPA, her body weight gain, was observed, and the dosage of MPA was reduced from 1,200 mg/day to 800 mg/day." | 1.31 | [A case of long surviving advanced recurrent breast cancer with multiple bone metastases responding to treatment with 5'-DFUR combined with MPA]. ( Otsuka, T; Tashiro, S; Terashima, Y, 2002) |
| "We experienced 522 patients with breast carcinoma and 14 cases (2." | 1.29 | [A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy]. ( Matsumine, T; Matsumoto, J; Minami, T; Takami, M; Takanishi, K, 1996) |
| "However, metastatic bone tumors from gastric cancer usually resist any treatments." | 1.28 | [A case of gastric cancer with recurrent bone metastases successfully treated with induced hypertension chemotherapy using cisplatin]. ( Furuya, K; Kashu, Y; Kiyasu, Y; Moriuchi, A; Sakai, K; Satoh, H; Shigematsu, S; Tanaka, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (10.53) | 18.7374 |
| 1990's | 12 (31.58) | 18.2507 |
| 2000's | 20 (52.63) | 29.6817 |
| 2010's | 2 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, F | 1 |
| Xiang, Y | 1 |
| Wan, X | 1 |
| Geng, S | 1 |
| Wang, T | 1 |
| Kusama, M | 2 |
| DOWD, JE | 1 |
| DIPAOLO, JA | 1 |
| WATNE, AL | 1 |
| Tomono, H | 1 |
| Kitamura, H | 1 |
| Iwase, M | 1 |
| Kuze, S | 1 |
| Ohi, S | 1 |
| Itoh, Y | 1 |
| Nakazawa, H | 1 |
| Fujita, H | 1 |
| Oya, J | 1 |
| Ishii, K | 1 |
| Tsugawa, K | 1 |
| Nakamura, M | 1 |
| Ohnishi, I | 1 |
| Miwa, K | 1 |
| Iba, T | 2 |
| Kidokoro, A | 2 |
| Fukunaga, M | 2 |
| Sugiyama, K | 2 |
| Aihara, N | 2 |
| Suda, M | 2 |
| Suda, T | 1 |
| Sakamoto, E | 1 |
| Hasegawa, H | 1 |
| Komatsu, S | 1 |
| Hiromatsu, T | 1 |
| Itazu, K | 1 |
| Tabata, T | 1 |
| Kawai, K | 1 |
| Fukami, Y | 1 |
| Kihara, M | 2 |
| Kontani, K | 1 |
| Yamauchi, A | 1 |
| Yokomise, H | 1 |
| Morin, KW | 1 |
| Duan, W | 1 |
| Knaus, EE | 1 |
| McEwan, AJ | 1 |
| Wiebe, LI | 1 |
| Hiraga, T | 1 |
| Hata, K | 1 |
| Ikeda, F | 1 |
| Kitagaki, J | 1 |
| Fujimoto-Ouchi, K | 1 |
| Tanaka, Y | 1 |
| Yoneda, T | 1 |
| Suzuki, S | 1 |
| Sekikawa, K | 1 |
| Fujita, S | 1 |
| Abe, N | 1 |
| Ishigame, T | 1 |
| Okada, R | 1 |
| Gonda, K | 1 |
| Saito, M | 1 |
| Onogi, H | 1 |
| Ohki, S | 1 |
| Takenoshita, S | 2 |
| Ikeda, M | 1 |
| Sonoo, H | 2 |
| Tanaka, K | 1 |
| Kurebayashi, J | 1 |
| Morimoto, T | 2 |
| Tangoku, A | 1 |
| Komaki, K | 1 |
| Kataoka, T | 1 |
| Ishiguro, K | 1 |
| Yoshizawa, K | 1 |
| Masumori, N | 1 |
| Kunishima, Y | 1 |
| Hirobe, M | 1 |
| Takeuchi, M | 1 |
| Takayanagi, A | 1 |
| Tsukamoto, T | 1 |
| Itoh, T | 1 |
| Barone, RM | 1 |
| Byfield, JE | 1 |
| Goldfarb, PB | 1 |
| Frankel, S | 1 |
| Ginn, C | 1 |
| Greer, S | 1 |
| Li, W | 1 |
| Fan, J | 1 |
| Hochhauser, D | 1 |
| Banerjee, D | 1 |
| Zielinski, Z | 1 |
| Almasan, A | 1 |
| Yin, Y | 1 |
| Kelly, R | 1 |
| Wahl, GM | 1 |
| Bertino, JR | 1 |
| Toi, M | 1 |
| Taniguchi, T | 1 |
| Hayashi, K | 1 |
| Tominaga, T | 1 |
| Takeshita, T | 1 |
| Masuyama, H | 1 |
| Shimizu, S | 1 |
| Tanahasi, T | 1 |
| Suzuki, H | 1 |
| Toyama, T | 1 |
| Matsumoto, J | 1 |
| Minami, T | 1 |
| Takami, M | 1 |
| Takanishi, K | 1 |
| Matsumine, T | 1 |
| Matsusaka, K | 1 |
| Miyauchi, A | 1 |
| Maeda, M | 1 |
| Fujitake, S | 1 |
| Maeda, Y | 1 |
| Shimizu, M | 1 |
| Nozaki, H | 1 |
| Tohyama, M | 1 |
| Kataoka, S | 1 |
| Senoo, T | 1 |
| Nishiki, M | 1 |
| Takashima, S | 1 |
| Tadaoka, N | 1 |
| Nakamura, Y | 1 |
| Mizutani, H | 1 |
| Kuroda, T | 1 |
| Takahashi, N | 1 |
| Kokufu, I | 2 |
| Taniguchi, H | 2 |
| Kim, YH | 2 |
| Fukuda, K | 2 |
| Yamamoto, M | 2 |
| Yano, T | 2 |
| Yamada, K | 2 |
| Kitano, H | 2 |
| Tanaka, R | 1 |
| Fukushima, H | 1 |
| Sato, K | 1 |
| Matsuda, M | 1 |
| Hanaoka, T | 1 |
| Goya, T | 1 |
| Oura, S | 1 |
| Sakurai, T | 1 |
| Yoshimura, G | 1 |
| Tamaki, T | 1 |
| Umemura, T | 1 |
| Kokawa, Y | 1 |
| Naito, Y | 1 |
| Matsuoka, T | 1 |
| Nomizu, T | 1 |
| Yabuta, T | 1 |
| Katagata, N | 1 |
| Watanabe, F | 1 |
| Yamaki, Y | 1 |
| Tsuchiya, A | 1 |
| Watanabe, Y | 1 |
| Kaiga, T | 1 |
| Ueda, T | 1 |
| Fujii, M | 1 |
| Fukuda, Y | 1 |
| Hirao, S | 1 |
| Koyama, I | 1 |
| Takatori, H | 1 |
| Terakura, M | 1 |
| Mayumi, K | 1 |
| Tsukazaki, Y | 1 |
| Kinoshita, H | 1 |
| Otsuka, T | 1 |
| Terashima, Y | 1 |
| Tashiro, S | 1 |
| Miyamoto, H | 1 |
| Yoshida, S | 1 |
| Imatomi, M | 1 |
| Saitoh, T | 1 |
| Nakata, A | 1 |
| Kaise, H | 1 |
| Nakayama, S | 1 |
| Ota, D | 1 |
| Aoki, T | 1 |
| Koyanagi, Y | 1 |
| Misaka, T | 1 |
| Matunaga, T | 1 |
| Koh, J | 1 |
| Murayama, Y | 1 |
| Sano, M | 1 |
| Katai, H | 1 |
| Maeda, K | 1 |
| Sakai, S | 1 |
| Yamamoto, O | 1 |
| Hashimoto, M | 1 |
| Hosoda, Y | 1 |
| Kiyasu, Y | 1 |
| Kashu, Y | 1 |
| Sakai, K | 1 |
| Shigematsu, S | 1 |
| Tanaka, T | 1 |
| Furuya, K | 1 |
| Moriuchi, A | 1 |
| Satoh, H | 1 |
| Hoshino, A | 1 |
| Ohara, K | 1 |
| Kamiya, O | 1 |
| Nagata, K | 1 |
| Ono, Y | 1 |
| Kawakubo, A | 1 |
| Ozaki, Y | 1 |
| Suzuki, A | 1 |
| Ogasawara, T | 1 |
| Sugiura, I | 1 |
| Reichman, BS | 1 |
| Kemeny, NE | 1 |
| Yeh, SD | 1 |
6 trials available for floxuridine and Bone Neoplasms
| Article | Year |
|---|---|
The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast | 2004 |
[Evaluation of safety and efficacy for bi-weekly Docetaxel and 5'-DFUR combination therapy in patients with advanced or recurrent breast cancer--Phase I study].
Topics: Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Ne | 2006 |
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 1995 |
[Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Adm | 1999 |
[The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
Topics: Adult; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Adm | 2001 |
[Clinical trial of a new fluorinated pyrimidine, 5'-deoxy-5-fluorouridine (5'-DFUR)].
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Drug Admin | 1986 |
32 other studies available for floxuridine and Bone Neoplasms
| Article | Year |
|---|---|
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Dru | 2011 |
[Doxifluridine, medroxyprogesterone acetate and cyclophosphamide(DMpC)combination therapy found effective for case of chest wall recurrent breast cancer with bone and pleural metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophospha | 2012 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neop | 1964 |
[A case of advanced breast cancer with multiple lung, bone and lymph node metastases successfully treated with 5'-DFUR alone].
Topics: Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; | 2003 |
[A case of breast cancer with lung and bone metastasis treated successfully by oral combination chemotherapy of 5'-deoxy-5-fluorouridine and cyclophosphamide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, | 2003 |
[Effective reduction of elevated tumor markers by exemestane--a 12-year follow-up of a case of bone metastatic breast cancer].
Topics: Aged; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocol | 2005 |
[A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2005 |
[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast | 2005 |
A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2'-fluoro-2'-deoxyuridine.
Topics: Bone Neoplasms; Cell Line, Tumor; Floxuridine; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; O | 2005 |
Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Capec | 2005 |
[A case of recurrent gastric cancer effectively treated by combination chemotherapy of weekly paclitaxel and 5'- DFUR after showing resistance to weekly paclitaxel].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Moda | 2006 |
Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer.
Topics: Antimetabolites, Antineoplastic; Area Under Curve; Bone Neoplasms; Cystectomy; Deoxycytidine; Fatal | 2008 |
Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases.
Topics: Adult; Aged; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Drug Admin | 1982 |
Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Base Sequence; Bone Neoplasms; Cell Division | 1995 |
[A case of long surviving inflammatory breast cancer with bone metastasis, treated by intra-arterial infusion chemotherapy followed by extended mastectomy].
Topics: Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Female; Floxuridine; Humans; | 1993 |
[A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Femal | 1996 |
[A case of stage IV breast cancer showing long-term complete response to combination therapy with 5'-DFUR and MPA].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Ne | 1998 |
[A case of giant advanced breast cancer responding remarkably to chemo-endocrine therapy chiefly with doxifluridine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, D | 1998 |
[Endocrine chemotherapy (high-dose toremifene + 5'-DFUR) found markedly effective for 2 cases of metastatic breast cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Flox | 1999 |
[A case of adriamycin and methotrexate-resistant recurrent breast cancer treated with doxifluridine and mitomycin C].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1999 |
[Successful endocrine chemotherapy in patients with multiple bone metastases of breast cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality | 1999 |
[Pain relief with alendronate therapy in a breast cancer patient with bone metastasis].
Topics: Aged; Alendronate; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Ne | 2000 |
[Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administratio | 2000 |
[A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Dr | 2000 |
[A case of advanced breast cancer that responded remarkably to chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; | 2000 |
[Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bre | 2001 |
[A case of long surviving advanced recurrent breast cancer with multiple bone metastases responding to treatment with 5'-DFUR combined with MPA].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bre | 2002 |
[Successful treatment of advanced recurent breast cancer using DMpC therapy as maintenance therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophospha | 2002 |
[A case of breast cancer with multiple bone metastases that responded remarkably to doxifluridine (5'-DFUR), cyclophosphamide (CPA), medroxyprogesterone acetate (MPA) and pamidronate disodium therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; | 2002 |
[A case of advanced breast cancer responding to low-dose 5'-DFUR].
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; | 1992 |
[A case of gastric cancer with recurrent bone metastases successfully treated with induced hypertension chemotherapy using cisplatin].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Bone and Bones | 1992 |
A complication of prolonged infusional chemotherapy masquerading as a bone metastasis in a patient with colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Bone Neoplasms; Catheterization; Floxuridine; Humans; Liver Neoplasms; Male; | 1987 |